文献速递血栓与止血

简化日内瓦医院相关静脉血栓栓塞风险评估模型在帕多瓦队列中的外部验证

External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort.
PubMed 文献 · J Thromb Haemost · 2019-12-16

本研究为前瞻性队列的二次分析,纳入1180例内科住院患者,外部验证简化日内瓦风险评估模型对住院相关静脉血栓栓塞的预测效能。结果显示该模型区分度优秀,高危组90天VTE风险为5.2%,低危组为0.4%,高危组风险比低危组高18倍(HR 17.9,95%CI 4.3-74.7)。

要点

  • 简化日内瓦模型将56.9%患者归为高危,高危组90天VTE风险5.2%。
  • 低危组90天VTE风险仅0.4%,高危组风险比为17.9(95%CI 4.3-74.7)。
  • 极高危组(≥7分)占5.3%,90天VTE概率为9.5%。

核心结论

  • 简化日内瓦风险评估模型在外部验证中显示出优秀的区分度和临床可接受的校准度,可作为指导血栓预防的分层工具。

研究设计与样本

  • 前瞻性队列的二次分析,设置于帕多瓦,共纳入1180例内科住院患者,随访90天观察裁定性VTE事件。

主要发现

  • 1180例内科住院患者中,90天症状性VTE风险为3.1%。
  • 简化日内瓦模型将56.9%患者归为高危(≥3分),其90天VTE风险为5.2%;43.1%归为低危(<3分),90天VTE风险为0.4%。
  • 与低危组相比,高危组VTE风险比为17.9(95%CI 4.3-74.7)。
  • 极高危类别(≥7分)识别出5.3%的患者,其90天VTE概率为9.5%。

关键数值与推荐

  • 高危定义为简化日内瓦评分≥3分,低危为<3分,极高危为≥7分。
  • 高危组90天VTE风险5.2%,低危组0.4%,极高危组9.5%。
  • 高危组与低危组相比的HR为17.9(95%CI 4.3-74.7)。

临床怎么用

  • 可将简化日内瓦风险评估模型用于内科住院患者,以分层指导血栓预防的使用。
  • 评分≥3分者90天VTE风险较高,评分<3分者风险很低,可辅助临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The simplified Geneva risk assessment model (RAM) predicts the risk of hospitalization-related venous thromboembolism (VTE) in medical inpatients in its developmental cohort but has not been validated. OBJECTIVES: To externally validate the simplified Geneva RAM. PATIENTS/METHODS: For this secondary analysis of a prospective cohort set in Padua, we calculated the simplified Geneva RAM for all participants. They were followed up for 90 days for the occurrence of adjudicated VTE. Thirty- and 90-day risks of VTE were estimated by the Kaplan-Meier method, and categories of risks compared with a Cox regression model adjusted for the use of thromboprophylaxis. RESULTS: Among 1180 medical inpatients, the 90-day risk of symptomatic VTE was 3.1%. The simplified Geneva RAM classified 56.9% as high risk (≥3 points; 90-day risk of VTE of 5.2%) and 43.1% as low risk (<3 points; 90-day risk of VTE of 0.4%). Compared with low-risk participants, high-risk participants had an 18-fold greater risk of VTE than low-risk participants (hazard ratio [HR] 17.9, 95% confidence interval [CI] 4.3-74.7). A very high-risk category (≥7 points) identified 5.3% of participants with a 9.5% probability of VTE at 90 days. CONCLUSIONS: In this external validation study, we confirm the excellent discrimination and clinically adequate calibration of the simplified Geneva RAM as a stratification tool to guide the use of thromboprophylaxis.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Blondon M, Righini M, Nendaz M, et al. External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort. J Thromb Haemost. 2019. PMID: 31782886. doi:10.1111/jth.14688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。